UK markets closed

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
94.32-0.05 (-0.05%)
At close: 04:00PM EDT
94.15 -0.17 (-0.18%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 58.08B
Enterprise value 57.27B
Trailing P/E 38.44
Forward P/E 36.23
PEG ratio (5-yr expected) 2.89
Price/sales (ttm)11.00
Price/book (mrq)9.94
Enterprise value/revenue 10.69
Enterprise value/EBITDA 29.90

Trading information

Stock price history

Beta (5Y monthly) 1.16
52-week change 3-1.18%
S&P500 52-week change 3-7.05%
52-week high 3131.73
52-week low 391.52
50-day moving average 3110.64
200-day moving average 3114.37

Share statistics

Avg vol (3-month) 32.76M
Avg vol (10-day) 32.9M
Shares outstanding 5621.75M
Implied shares outstanding 6N/A
Float 8616.25M
% held by insiders 10.79%
% held by institutions 185.12%
Shares short (28 Apr 2022) 44.86M
Short ratio (28 Apr 2022) 41.64
Short % of float (28 Apr 2022) 40.79%
Short % of shares outstanding (28 Apr 2022) 40.78%
Shares short (prior month 30 Mar 2022) 44.46M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 23:1
Last split date 331 May 2020

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)30 Mar 2022


Profit margin 28.72%
Operating margin (ttm)30.69%

Management effectiveness

Return on assets (ttm)13.15%
Return on equity (ttm)29.30%

Income statement

Revenue (ttm)5.36B
Revenue per share (ttm)8.60
Quarterly revenue growth (yoy)10.20%
Gross profit (ttm)3.98B
Net income avi to common (ttm)1.54B
Diluted EPS (ttm)2.43
Quarterly earnings growth (yoy)10.50%

Balance sheet

Total cash (mrq)1.5B
Total cash per share (mrq)2.41
Total debt (mrq)688.2M
Total debt/equity (mrq)11.77
Current ratio (mrq)3.41
Book value per share (mrq)9.41

Cash flow statement

Operating cash flow (ttm)1.72B
Levered free cash flow (ttm)1.12B